Table.
Clinical indicators (recognized standards for diabetes care) | Participants, N | Mean baseline measure | Mean interim measure | Mean change |
---|---|---|---|---|
A1c (American Diabetes Association goal: <7.0%) | 1580 | 9.0% | 8.3% | −0.7%a |
LDL cholesterol level (NCEP goal: <100 mg/dL) | 966 | 99.5 mg/dL | 92.2 mg/dL | −7.3 mg/dLa |
Systolic blood pressure (JNC VIIb goal: <130 mm Hg) | 1702 | 131.8 mm Hg | 129.9 mm Hg | −1.9 mm Hga |
Body mass index (World Health Organization normal: 18.5–24.9 kg/m2) | 1699 | 35.1 kg/m2 | 34.9 kg/m2 | −0.2 kg/m2a |
Participant demographics | ||||
Sex | ||||
Women, 58.3% | ||||
Men, 41.7% | ||||
Age (average, 53.8 yrs) | ||||
≥50 yrs, 67.6% | ||||
≥62 yrs, 23.4% | ||||
Ethnicity | ||||
Caucasian, 41.2% | ||||
African American, 24.2% | ||||
Hispanic, 21.3% | ||||
Other, including not specified, 13.4% |
Statistically significant change.
National Institutes of Health Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. December 2003.
A1c indicates glycosylated hemoglobin; JNC VII, The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; LDL, low-density lipoprotein; NCEP, National Cholesterol Education Program.
Copyright © 2013 APhA Foundation. Used with permission.